Previous studies imply that the intracellular domain of Notchl must translocate to the nucleus for its activity. In this study, we demonstrate that a mNotch 1 mutant protein that lacks its extracellular domain but retains its membrane-spanning region becomes proteolytically processed on its intracellular surface and, as a result, the activated intracellular domain (mNotchIC) is released and can move to the nucleus. Proteolytic cleavage at an intracellular site is blocked by protease inhibitors. Intracellular cleavage is not seen in cells transfected with an inactive variant, which includes the extracellular lin-Notch-glp repeats. Collectively, the studies presented here support the model that mNotchl is proteolytically processed and the cleavage product is translocated to the nucleus for mNotchl signal transduction.
Signaling through the Notch/Linl2 family of receptors regulates cell fate choice throughout development, but the molecular nature of the signaling pathway remains poorly understood. Although these receptors are transmembrane proteins activated by an emerging family of ligands (1) , they may also be constitutively activated by truncation of the extracellular domain. Two forms of constitutively activated Notch proteins have been reported: deletions removing specific portions or all of the extracellular domain but retaining the transmembrane domain (2) (3) (4) (5) and deletions resulting in an intracellular fragment of Notch (2, 4, 6, 7) . The active untethered intracellular fragments of Notch family members encode nuclear localization sequences and are found in the nucleus. Recently, we showed that nuclear localization of the truncated intracellular protein, mNotchIC, is required for its ability to inhibit myogenesis in fibroblasts (6) . Recent data demonstrate that mNotchIC interacts directly with KBF2/RBP-Jk in nuclear extracts to augment its ability to activate transcription of the HES-1 promoter. These experiments raise the question as to how endogenous mNotchl, a membrane-spanning protein, obtains access to the nucleus.
The existence of an in vitro assay for activated, membranespanning Notchl molecules allows us to address the mechanism of Notch signaling. In this study, we compare the efficacy of membrane-spanning, epitope-labeled mNotchl derivatives in inhibiting myogenesis to the proteolytic cleavage and subcellular localization of the resulting polypeptides. A mNotchl derivative, lacking the extracellular domain but retaining the membrane-spanning domain, displays inhibitory activity on muscle-specific promoters and myogenesis (this work) and activates the HES-1 promoter (8) . We now demonstrate that the membrane tether is proteolytically cleaved to release an activated intracellular fragment, which translocates to the nucleus, and that the cleavage is inhibited by protease inhib-
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itors. These observations support a model for signal transduc (8) contain the C terminus and one Myc-tag as described (10) Immunostaining. Frog embryos were injected and processed as described (6) . Myc-tagged Notch was detected in frogs by the monoclonal anti-myc antibody (9E10; ref. 13 ) and alkaline phosphatase-conjugated anti-mouse secondary antibodies (see Fig. 2 ). These constructs were tested for myogenic inhibition in fibroblasts (6) . mNotchAE lowered the ability of MyoD to activate MCKCAT and blocked its ability to convert 3T3 cells to muscle (Fig. 1B) . The overall activity of mNotchAE was equivalent to the intracellular portion of mNotch (mNotchIC), with 90-99% inhibition of MyoD (ref. 6 ; Fig. 1 D and D' ). In contrast, LNGmNotch had no effect on MyoD's ability to convert 3T3 cells into myocytes or to induce expression from MCKCAT (Fig. 1A) .
Since the membrane-tethered mNotchAE exhibited activity similar to that of the mNotchIC intracellular fragment, we wondered whether the intracellular domain of mNotchAE became localized to the nucleus, as observed with mNotchIC (6, 10 (Fig. 2B) , while embryos injected with LNGmNotch showed only membrane staining ( Fig. 2A) . Similar results have been observed in Drosophila, using zECN Notch (33) . Previously, we demonstrated that mNotchIC acts as an inhibitor of myogenesis in frog embryos (6 (Fig. 1C' ) in addition to its C-terminal Myc tag. Its activity in the myogenic inhibition assay was similar to that of mNotchAE (Fig. 1C) . In transfected, paraformaldehyde fixed, unpermeabilized fibroblasts, the HA epitope was detected at the extracellular surface (Fig. 2C) . The myc epitope was found in the membrane and in vesicle-like bodies (Fig. 2C, arrows) . Following Triton X-100 permeabilization (Fig. 2D) HA-positive cells also stain for myc (compare Fig. 2 C and D) . In permeabilized cells, we detect 10% of cells in which Myc staining is exclusively nuclear (Fig.   2E ). These data show that the N and C termini have different subcellular dispositions: HAmNotchAE is inserted into the membrane, but fragments containing the C-terminal myc epitope are also found in a vesicular compartment of unknown nature (10, 14) and in the nucleus.
The Difference of Subcellular Localizations Can Be Explained by Proteolytic Processing. To determine whether proteolysis was occurring, we performed Western blot analysis and pulse-chase experiments of transiently transfected 3T3 cells with the tagged mNotch derivatives. When probed with an anti-Myc antibody, extracts of cells transfected with mNotchAE revealed three fragments of an apparent molecular mass between 63 and 81 kDa (Fig. 3, lane A) . To determine which fragment contained the N terminus in addition to the Myc-tagged C terminus, we examined HAmNotchAE. A triplet of products was observed, the largest of which was 83 kDa, a size equivalent to the largest mNotchAE band plus the added HA sequence. The apparent size of the two smaller products, however, remained unchanged (arrows in Fig. 3 ; compare lane A with lane C). Immunoprecipitation with the anti-HA antibody 12CA5 precipitated only the 83-kDa product (Fig. 3, lane  D all cells show accumulation of products in the nucleus to the same degree (see also ref. 8). In the frog ectoderm, it appears that nuclear transport of mNotchAE fragments is occurring at a much higher degree than in transiently transfected 3T3 cells (Fig. 2) .
To unequivocally determine the identity of the 63-to 81-kDa fragments, we microsequenced gel-purified peptides. The N terminus of the 70-kDa fragment of mNotchAE is MYVAA, consistent with the sequence at amino acid 1726 of mNotch 1 (see Fig. 4 ). An N-terminal methionine raises the possibility of an alternative translation initiation. The internal M1726 is the first AUG in any frame following the Notchl initiation methionine in mNotchAE. This methionine and the methionine at position 1796 are conserved in mNotchl from all species. Therefore, the activity of membrane-tethered Notchl with large deletions of extracellular sequences could possibly be due to the proximity of an alternative translation initiation site downstream of the normal Notchl translation start site. Such an initiation site would generate a protein that lacks the signal peptide, remains in the cytoplasm, and could translocate to the nucleus.
We introduced mutations that altered the methionine (M1726V or M1726A) to eliminate alternative initiation at this site. Western blots of M1726A and M1726V lack the 70-kDa polypeptide, whereas the 63-kDa fragment is unaffected (Fig.  4) . Both mNotchAEM1726V and mNotchAEM1726A show inhibitory activity in myogenesis and stimulate HES-1 transcription; exclusive nuclear staining is detected in 10% of transfected cells (data not shown). This suggests that the 70-kDa alternative translation product and methionine-1726 are not required for activity.
To establish that the 63-kDa fragment represents a cleavage product formed during mNotchAE signaling, pulse-chase experiments were performed. A short (10 min) pulse followed by a chase in the presence of cycloheximide labeled both the 81-and the 70-kDa fragments (Fig. 4B) . The 63-kDa fragment accumulated only during the chase, requiring 30-60 min posttranslation in both mNotchAE and mNotchAEM1726V (Fig. 4A ). (Fig. 4B) . The transmembrane domain extends to amino acid 1740, making cleavage upstream of amino acid 1740 unlikely, but we cannot rule out this possibility.
Generation of the 63-kDa Fragment Is Blocked by Protease Inhibitors. We tried several protease inhibitors in an effort to block the putative protease. The peptidyl aldehyde inhibitor N-Cbz-L-Leu-L-Leu-Leu-H (MG132), but not related inhibitors (calpain I and calpain II inhibitors), eliminated the 63-kDa cleavage product but not the 70-kDa translation product (Fig.  5, lanes A-E) . Similar results were obtained with mNotchAEM1726V where long exposure reveals complete disappearance of the 63-kDa fragment (lanes F-H). Collectively, these results clearly demonstrate that the 63-kDa fragment is a proteolytic product of the 81-kDa fragment. The LNG Repeats May Regulate Intracellular Processing. The inactive LNGmNotch is also partially cleaved in transfected cells (Fig. 3, lane B) , resulting in about half of the protein in the form of a shorter fragment (86 kDa). We isolated protein to identify the position of this cleavage site. Microsequencing of the N terminus of the 86-kDa cleavage product revealed the sequence ELDPMDI, which corresponds to extracellular amino acids 1655-1661. These amino acids are preceded by a typical serine protease site (RQRR), conserved in all Notchl orthologues. The resulting inactive protein consists of the extracellular stalk with its conserved cysteines and the entire intracellular domain. These cysteine residues have apparent roles in preventing activation and possibly dimerization of Drosophila Notch (2, 15) . It is likely that this fragment corresponds to the inactive 100/120-kDa fragment seen by others in cells expressing full-length TAN-1 or Notch, respectively (16, 17) . The size differences between the 100/ 120-kDa fragments and our 86-kDa fragment are due to the removal of the C terminus in our LNGmNotch ( (19) .
(2) Transcription of HES-1 produces a basic helix-loop-helix (bHLH) protein that negatively regulates other cell type-specific bHLH proteins, such as MyoD (18) . (4) In Drosophila, other molecules such as Hairless (20) also regulate Su(H) activity in the nucleus (20) (21) (22) (23) (24) (25) . A similar mechanism of activation employing cleavage of a membrane-tethered transcription factor, the sterol regulatory element binding protein 1 (SREBP-1), has been recently reported (26 (16, 17, 29) . Moreover, constructs used in these experiments lack PEST sequences thought to regulate protein degradation (30) . The subsequent degradation of the 63-kDa fragment may have been slowed due to a lack of these sequences. In addition, rapid turnover is observed in nuclei overexpressing the intracellular fragment of Notch (2) . This is consistent with speculation that intracellular peptides of wildtype Notch have extremely short half-lives and are not easily detected. However, it still remains to be proven that such processing takes place during ligand-dependent signaling.
How does ligand activate mNotch signaling? It has been shown in Drosophila that Notch sequesters Su(H) in the cytoplasm and ligand binding to Notch leads to its release (29, 31, 32) . This model poses the problem as to what the distribution of Su(H) might be in the absence of Notch. The model predicts that both ligand-activated and null Notch lead to Su(H) translocation to the nucleus, a prediction that is inconsistent with the observed phenotypes (29, 31) . One possible solution to this problem would be if the interaction of Su(H) and Notch led to a modification of Su(H), such that Su(H) was activated. Alternatively, if Notch fragments were translocated to the nucleus following ligand activation as we propose (see below), then the Notch-Su(H) complex would be positioned to activate or repress genes in the nucleus.
We propose that ligand binding to the extracellular domain may also regulate processing of Notch. Our data demonstrate that the presence of LNG repeats alters intracellular processing, and their removal activates mNotchl (2) . One possible model to account for the modulation of intracellular proteolysis by the extracellular domains would be if the extracellular domain regulated oligomer formation (ref. 14; see Fig. 6A ). Oligomerization and the consequent close apposition of the intracellular surfaces may regulate access of an intracellular protease to the stalk region. Hypothetically, the interaction of ligand with Notch family members may then alter the oligomerization state of the molecules and lead to proteolytic cleavage, nuclear localization, and activation of Su(H) (8) . Although we demonstrate the existence of such a mechanism only in active truncated mNotch mutants, we suggest that the endogeneous Notch family may undergo the same cleavage and nuclear localization to exert their effects upon cell fate and other processes.
